Ypsomed Holding AG (YPSN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Ypsomed Holding AG (YPSN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7140
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ypsomed Holding AG (Ypsomed) is a medical device company that designs, develops and manufactures injection and infusion systems for self-medication and offers related services. It offers autoinjectors, dual chamber pens, and pen injectors. The company also offers services ranging from design and development projects, flexible prototyping, human factors engineering, and IP landscape management to manufacturing and assembly infrastructure and registration support. Ypsomed offers solutions to physicians, and pharmaceutical and biotechnology companies. The company’s products find application in the treatment of diabetes, infertility, growth disorders and various other clinical indications. The company operates through its subsidiaries and distributors across the world. Ypsomed is headquartered in Burgdorf, Switzerland.

Ypsomed Holding AG (YPSN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ypsomed Holding AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Ypsomed Holding AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Ypsomed Holding AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Ypsomed Holding AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Ypsomed Holding AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Ypsomed Holding AG, Medical Equipment, Deal Details 10
Asset Purchase 10
Ypsomed Plans to Acquire Injection System Business in China 10
Partnerships 11
Ypsomed to Enter into Agreement with Philips 11
Bigfoot Biomedical Enters into Agreement with Ypsomed 12
Ypsomed Enters into Distribution Agreement with Tonghua Dongbao Pharma 13
Thin Film Electronics Partners with Ypsomed 14
Ypsomed Partners with Tonghua Dongbao Pharma 15
Insulet Expands Distribution Agreement With Ypsomed Holding 16
Acquisition 17
Ypsomed Plans To Sell DiaExpert, Diabetes Products Provider 17
Ypsomed Holding AG – Key Competitors 18
Ypsomed Holding AG – Key Employees 19
Ypsomed Holding AG – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Strategy And Business Planning 21
Jun 29, 2018: Topping-out ceremony at the new Ypsomed site in Schwerin 21
Sep 27, 2017: Go-ahead for Ypsomed’s new production facility in Schwerin 22
May 10, 2017: Ypsomed expands to more countries 23
Jan 25, 2017: Ypsomed opens a new production line in Solothurn 24
Financial Announcements 25
May 24, 2018: Ypsomed significantly increases turnover and invests more in the future 25
Nov 09, 2017: Ypsomed Grows during First half-year and Raises its Forecast for the Year 27
May 24, 2017: Ypsomed accelerates growth significantly 29
Corporate Communications 31
Jun 27, 2018: Change in the Board of Directors of the Ypsomed Group 31
Other Significant Developments 32
Oct 24, 2017: Ypsomed supplies Bigfoot Biomedical with infusion sets 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Ypsomed Holding AG, Medical Equipment, Key Facts, 2018 2
Ypsomed Holding AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Ypsomed Holding AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Ypsomed Holding AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Ypsomed Holding AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Ypsomed Holding AG, Deals By Market, 2012 to YTD 2018 8
Ypsomed Holding AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Ypsomed Plans to Acquire Injection System Business in China 10
Ypsomed to Enter into Agreement with Philips 11
Bigfoot Biomedical Enters into Agreement with Ypsomed 12
Ypsomed Enters into Distribution Agreement with Tonghua Dongbao Pharma 13
Thin Film Electronics Partners with Ypsomed 14
Ypsomed Partners with Tonghua Dongbao Pharma 15
Insulet Expands Distribution Agreement With Ypsomed Holding 16
Ypsomed Plans To Sell DiaExpert, Diabetes Products Provider 17
Ypsomed Holding AG, Key Competitors 18
Ypsomed Holding AG, Key Employees 19
Ypsomed Holding AG, Subsidiaries 20

List of Figures
Ypsomed Holding AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Ypsomed Holding AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Ypsomed Holding AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Ypsomed Holding AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Ypsomed Holding AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Ypsomed Holding AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Ypsomed Holding AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Ypsomed Holding AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Ypsomed Holding AG (YPSN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IOOF Holdings Ltd (IFL):企業の財務・戦略的SWOT分析
    IOOF Holdings Ltd (IFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Onxeo SA:企業のM&A・事業提携・投資動向
    Onxeo SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Onxeo SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Bharti Infratel Ltd:企業の戦略・SWOT・財務分析
    Bharti Infratel Ltd - Strategy, SWOT and Corporate Finance Report Summary Bharti Infratel Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Mediaset SpA (MS)
    Mediaset SpA (MS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • SuperSonic Imagine SA (SSI):企業の財務・戦略的SWOT分析
    Summary SuperSonic Imagine SA (SuperSonic) operates as a medical device company that develops and supplies ultrasound medical imaging systems for measuring and visualizing tissue elasticity. The company offers an ultrasound system, Aixplorer that finds clinical applications in breast, abdomen, liver …
  • Medical Information Technology, Inc.-医療機器分野:企業M&A・提携分析
    Summary Medical Information Technology, Inc. doing business as Meditech, is a healthcare information technology solutions provider. The company develops, manufactures, licenses and supports computer software products for hospital market. Its software solution supports the complete spectrum of health …
  • Encompass Health Corporation:企業の戦略・SWOT・財務情報
    Encompass Health Corporation - Strategy, SWOT and Corporate Finance Report Summary Encompass Health Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • PriceSmart, Inc.:企業の戦略・SWOT・財務分析
    PriceSmart, Inc. - Strategy, SWOT and Corporate Finance Report Summary PriceSmart, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Maxwell Technologies Inc. (MXWL):電力:M&Aディール及び事業提携情報
    Summary Maxwell Technologies, Inc. (Maxwell) formerly Maxwell Laboratories, Inc., is a manufacturer of capacitor-based energy storage systems and power delivery solutions. The company develops, manufactures and markets energy storage and power delivery products for transportation and other applicati …
  • TESARO Inc (TSRO):医療機器:M&Aディール及び事業提携情報
    Summary TESARO Inc (TESARO) is an oncology-focused biopharmaceutical company that focuses on developing in-licensed, oncology-related product candidates and discovery of new candidates. It develops products using different approaches, comprising small molecules and immuno-oncology antibodies. The co …
  • Interprotein Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Interprotein Corp (Interprotein) is a drug development company that develops active modulators for protein-protein interaction (PPI) targets. The company offers products such as IL-6 inhibitor, IgE inhibitor, notch1 inhibitor, tubulin polymerization inhibitors, TIM-3 inhibitor, NKG2A, HLA-E …
  • Biofortuna Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Biofortuna Ltd (Biofortuna) is a provider of contract services and molecular diagnostic products. The company distributes CE-marked and freeze-dried PCR diagnostic kits. It has freeze dried molecular diagnostic products targeted at the transplantation, disease identification and pharmacogene …
  • M.C. Dean, Inc.:戦略・SWOT・企業財務分析
    M.C. Dean, Inc. - Strategy, SWOT and Corporate Finance Report Summary M.C. Dean, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Byco Petroleum Pakistan Ltd (BYCO):企業の財務・戦略的SWOT分析
    Byco Petroleum Pakistan Ltd (BYCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • IXICO Plc (IXI):企業の財務・戦略的SWOT分析
    Summary IXICO Plc (IXICO), formerly Phytopharm plc is a provider of clinical trial services and technology for the evaluation of imaging endpoints and assessing the safety and efficacy of drugs. The company offers products such as Assessa and trial tracker. Assessa provides web-based platform to tra …
  • CytRx Corp (CYTR):製薬・医療:M&Aディール及び事業提携情報
    Summary CytRx Corp (CytRx) is a clinical state is a biopharmaceutical company focusing on the research and development of novel treatments for cancer. The company’s oncology based product comprises of its lead drug product candidate, aldoxorubicin (formerly INNO-206). Aldoxorubicin is a pro-drug of …
  • Asarco LLC:企業の戦略・SWOT・財務情報
    Asarco LLC - Strategy, SWOT and Corporate Finance Report Summary Asarco LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • The People’s Insurance Company (Group) of China Limited:戦略・SWOT・企業財務分析
    The People's Insurance Company (Group) of China Limited - Strategy, SWOT and Corporate Finance Report Summary The People's Insurance Company (Group) of China Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • Kone Corporation:企業の戦略・SWOT・財務分析
    Kone Corporation - Strategy, SWOT and Corporate Finance Report Summary Kone Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Ralph Lauren Corporation:戦略・SWOT・企業財務分析
    Ralph Lauren Corporation - Strategy, SWOT and Corporate Finance Report Summary Ralph Lauren Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆